CAS 55703-81-6

4-isopropyl-3,5-dimethoxybenzoic acid

Codes: BENV-008

Application context (from source-drug indications)

Plaque psoriasisBenvitimodAtopic dermatitisBenvitimodPsoriasisBenvitimodCutaneous T-cell lymphomaBenvitimodMycosis fungoidesBenvitimodMeleda diseaseBenvitimod

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Benvitimod	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

BenvitimodOptimised routesteps: 7total yield: 0.26 g (Benvitimod)

3,5-dihydroxybenzoic acid→methyl 3,5-dimethoxybenzoate→(4-isopropyl-3,5-dimethoxyphenyl)methanol→(E)-2-isopropyl-1,3-dimethoxy-5-styrylbenzene→4-isopropyl-3,5-dimethoxybenzoic acid→5-(chloromethyl)-2-isopropyl-1,3-dimethoxybenzene→diethyl (4-isopropyl-3,5-dimethoxybenzyl)phosphonate→benzaldehyde

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.